Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 200-911-5 | CAS number: 75-87-6
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Description of key information
Acute oral toxicity:
The acute oral toxicity dose (LD50) was considered based on different studies conducted on rats, mouse, rabbis and guinea pigs for the test chemical. The LD50 value is 850 mg/kg bw in rats. The study concluded that the LD50 value is between 300-2000 mg/kg bw, for acute oral toxicity. Thus, comparing this value and range with the criteria of CLP regulation, the given test chemical can be classified in ‘Category 4’ for acute oral toxicity.
Acute Inhalation Toxicity:
The LC50 value is ≤0.5 mg/L, for acute inhalation toxicity. Thus, comparing this value with the criteria of CLP regulation, the given test chemical can be classified in “Category 1” for acute inhalation toxicity.
Acute Dermal toxicity:
Acute dermal toxicity study was done in guinea pigs using test material.50% mortality observed at dose range 1510-15000 mg/kg, hence, LD50 was considered to be1510-15000 mg/kg body weight. When guinea pigs were treated with test chemical by dermal application.
Key value for chemical safety assessment
Acute toxicity: via oral route
Link to relevant study records
- Endpoint:
- acute toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- weight of evidence
- Reliability:
- 4 (not assignable)
- Rationale for reliability incl. deficiencies:
- secondary literature
- Justification for type of information:
- Data is from secondary source.
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- other: As mention below
- Principles of method if other than guideline:
- Acute oral toxicity study of the given test chemical was performed in Rat.
- GLP compliance:
- not specified
- Test type:
- other: not specified
- Limit test:
- no
- Species:
- rat
- Strain:
- not specified
- Sex:
- not specified
- Details on test animals or test system and environmental conditions:
- not specified
- Route of administration:
- oral: unspecified
- Vehicle:
- not specified
- Details on oral exposure:
- not specified
- Doses:
- 850 mg/kg
- No. of animals per sex per dose:
- not specified
- Control animals:
- not specified
- Details on study design:
- not specified
- Statistics:
- not specified
- Sex:
- not specified
- Dose descriptor:
- LD50
- Effect level:
- 850 mg/kg bw
- Based on:
- test mat.
- Remarks on result:
- other: 50% mortality observed
- Mortality:
- 50% mortality was observed at 850 mg/kg bw.
- Clinical signs:
- other: Somnolence (general depressed activity); Ataxia and Alteration of classical conditioning were observed in treated rats.
- Gross pathology:
- not specified
- Other findings:
- not specified
- Interpretation of results:
- Category 4 based on GHS criteria
- Conclusions:
- The acute oral LD50 value was considered to be 850 mg/kg body weight, when rats were treated with the given test chemical orally.
- Executive summary:
Acute oral toxicity study was done in rat using test material at dose concentration of 850 mg/kg bw. Animals were observed for mortality and signs of toxicity. 50% mortality observed at dose 850 mg/kg bw. Clinical signs like Somnolence (general depressed activity); Ataxia and Alteration of classical condition were observed. Hence, the acute oral LD50 value was considered to be 850 mg/kg body weight, when rats were treated with the given test chemical orally.
Reference
Endpoint conclusion
- Endpoint conclusion:
- adverse effect observed
- Dose descriptor:
- LD50
- Value:
- 850 mg/kg bw
- Quality of whole database:
- Data is from secondary source.
Acute toxicity: via inhalation route
Link to relevant study records
- Endpoint:
- acute toxicity: inhalation
- Type of information:
- experimental study
- Adequacy of study:
- weight of evidence
- Reliability:
- 4 (not assignable)
- Rationale for reliability incl. deficiencies:
- secondary literature
- Justification for type of information:
- Data is from secondary literature
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- other: As mention below
- Principles of method if other than guideline:
- Acute inhalation toxicity study of test chemical in albino rats
- GLP compliance:
- not specified
- Test type:
- other: not specified
- Limit test:
- no
- Species:
- rat
- Strain:
- Sprague-Dawley
- Sex:
- male
- Details on test animals or test system and environmental conditions:
- Details on test animal
TEST ANIMALS
- Source: No data available
- Age at study initiation: Specific age was not mention young rats were taken
- Weight at study initiation: 144 grams
- Fasting period before study: No data available
- Housing: in a stock cages
- Diet (e.g. ad libitum): standard laboratory diet (Purina Rat Chow)ad libitum
- Water (e.g. ad libitum): water ad libitum
- Acclimation period: No data available
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 25°C
- Humidity (%):No data available
- Air changes (per hr): No data available
- Photoperiod (hrs dark / hrs light): No data available
IN-LIFE DATES: From: To: No data available - Route of administration:
- inhalation: vapour
- Type of inhalation exposure:
- whole body
- Vehicle:
- clean air
- Remark on MMAD/GSD:
- No data available
- Details on inhalation exposure:
- No data available
- Analytical verification of test atmosphere concentrations:
- not specified
- Duration of exposure:
- 4 h
- Remarks on duration:
- total : 240min
- Concentrations:
- 0.24,0.36,0.38,0.71,6.32 mg/l
- No. of animals per sex per dose:
- Total :50
0.24mg/l :10
0.36mg/l:10
0.38mg/l:10
0.71mg/l:10
6.32mg/l:10 - Control animals:
- not specified
- Details on study design:
- - Duration of observation period following administration: 14 days
- Frequency of observations and weighing:
Weighing: Before and after inhalation
- Necropsy of survivors performed: yes
- Other examinations performed:
clinical signs: Yes
body weight: Yes, Before and after 14 days of observation
organ weights: yes
histopathology: No data available
other: - Statistics:
- Litchfield and Wilcoxon
- Preliminary study:
- No data available
- Sex:
- male
- Dose descriptor:
- LC50
- Effect level:
- 0.44 mg/L air
- Based on:
- test mat.
- 95% CL:
- > 0.38 - < 0.5
- Exp. duration:
- 240 min
- Remarks on result:
- other: mortality was observed
- Mortality:
- Mortality was observed at dose 0.36 and 0.38 at four to five days of exposure and at dose 0.71 and 6.32 death was observed at one to three days.
- Clinical signs:
- other: Sneezing was noted approximately one-half hour after the start of the inhalation period. Hypoactivity, ptosis, and dyspnea occurred at about one hour, with gasping and prostration at two to three hours.
- Body weight:
- At dose 0.24,0.36 and 0.38 body weight was observed as 70, 39 and 58 grams all are within the normal limits
- Gross pathology:
- Moderate to severe diffuse red discoloration of the lungs were seen. Three rats from Group 2 did not reveal any gross pathologic alteration
- Other findings:
- No data available
- Interpretation of results:
- Category 1 based on GHS criteria
- Conclusions:
- The LC50 value was considered to be 0.44 mg/l of air (vapour) .When rats were inhaled with the given test chemical.
- Executive summary:
Acute inhalation toxicity test was conducted in male rats of Sprague-Dawley strain. 5 groups of 10 rats were taken for test. Rats were exposed for 4 hrs and observed for 14 days. Body weight was measured before and after 14 days of observation. Gross pathology was conducted for the animal which died during test and after completion of observation period. At dose 0.24,0.36 and 0.38 body weight was observed as 70, 39 and 58 grams all are within the normal limits. Moderate to severe diffuse red discoloration of the lungs were seen. Mortality was observed at dose 0.36 and 0.38 at four to five days of exposure and at dose 0.71 and 6.32 death was observed at one to three days. Therefore, the LC50 was considered to be 0.44 mg/l of air (vapour) .When rats were inhaled with the given test chemical.
Reference
Acute Vapour Inhalation Toxicity study- Albino Rats
Mortality Data
Group |
Average. Nominal Vapour Concentration |
Number of Animals tested |
Observed precent death |
Expected percent death |
I |
0.24 |
10 |
0 |
0.01 |
II |
0.36 |
10 |
10 |
12.10 |
III |
0.38 |
10 |
20 |
20.00 |
VI |
0.71 |
10 |
100 |
99.86 |
V |
6.32 |
10 |
100 |
100 |
Acute Vapour Inhalation LC50 = 0.44mg,/L air (four-hour exposure)
LimitsofLC50 at the 95 %Levelofconfidence=0.38 – 0.50mg/L air
Endpoint conclusion
- Endpoint conclusion:
- adverse effect observed
- Dose descriptor:
- LC50
- Value:
- 0.44 mg/m³ air
- Quality of whole database:
- Data is from secondary source.
Acute toxicity: via dermal route
Link to relevant study records
- Endpoint:
- acute toxicity: dermal
- Type of information:
- experimental study
- Adequacy of study:
- weight of evidence
- Reliability:
- 4 (not assignable)
- Rationale for reliability incl. deficiencies:
- secondary literature
- Justification for type of information:
- Data is from secondary literature
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- other: As mention below
- Principles of method if other than guideline:
- Acute dermal toxicity study of 2, 2, 2-trichloroacetaldehyde was performed in guinea pig .
- GLP compliance:
- not specified
- Test type:
- other: not specified
- Limit test:
- no
- Specific details on test material used for the study:
- - Name of test material (as cited in study report):2, 2, 2-trichloroacetaldehyde
- Molecular formula :C2HCI3O
- Molecular weight :147.387 g/mole
- Substance type:organic
- Physical state:Liquid
Purity:No data available
- Impurities (identity and concentrations):No data available - Species:
- guinea pig
- Strain:
- not specified
- Sex:
- not specified
- Details on test animals or test system and environmental conditions:
- No data available
- Type of coverage:
- not specified
- Vehicle:
- not specified
- Details on dermal exposure:
- No data available
- Duration of exposure:
- No data available
- Doses:
- 1510-15000 mg/kg
- No. of animals per sex per dose:
- No data available
- Control animals:
- not specified
- Details on study design:
- No data available
- Statistics:
- No data available
- Preliminary study:
- No data available
- Sex:
- not specified
- Dose descriptor:
- LD50
- Effect level:
- 1 510 - 15 000 mg/kg bw
- Based on:
- test mat.
- Mortality:
- No data available
- Clinical signs:
- other: No data available
- Gross pathology:
- No data available
- Other findings:
- No data available
- Interpretation of results:
- other: No classified
- Conclusions:
- LD50 was considered in range of 1510-15000 mg/kg body weight, when guinea pigs were treated with the given test chemical by dermal application.
- Executive summary:
Acute dermal toxicity study was done in guinea pigs using test material.50% mortality observed at dose range 1510-15000 mg/kg ,hence, LD50 was considered to be1510-15000mg/kg body weight. When guinea pigs were treated with test chemical by dermal application.
Reference
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed
- Dose descriptor:
- LD50
- Value:
- 1 510 mg/kg bw
- Quality of whole database:
- Data is from secondary source.
Additional information
Acute oral toxicity:
In different studies, the given test chemical has been investigated for acute oral toxicity to a greater or lesser extent. Often are the studies based on in-vivo experiments in rodents, i.e. most commonly in rats, mouse, rabbits and guinea pigs for test chemical. The studies are summarized as below –
Acute oral toxicity study was done in rats, mice, guinea pigs and rabbits using test material at dose concentration of 850, 725, 940 and 1400 mg/kg bw respectively. Animals were observed for mortality and signs of toxicity. 50% mortality observed at dose 850, 725, 940 and 1400 mg/kg bw. Clinical signs like Somnolence (general depressed activity); Ataxia and Alteration of classical condition were observed. Hence, the acute oral LD50 value was considered to be 850, 725, 940 and 1400 mg/kg body weight respectively, when rats, mice, guinea pigs and rabbits were treated with the given test chemical orally.
This study is supported with another study mentioned in authoritative database for the given test chemical. The acute oral toxicity study was conducted at dose range of 50-400 mg/kg bw in rats. Animals were observed for mortality. Mortality was observed in between 50 -400 mg/kg bw. Hence, the acute oral toxicity dose, LD50 was considered to be in the range of 50-400 mg/kg body weight, when rats were treated with the given test chemical orally.
The above study is supported with the acute oral toxicity study done in rat using test chemical at 600 mg/kg bw. Animals were observed for mortality. 50% mortality observed at dose 600 mg/kg. Hence, the acute oral LD50 value was considered to be 600 mg/kg body weight, when rats were treated with the given test chemical orally
All the above studies are further supported with acute oral toxicity study done in rat using test material at 670 mg/kg bw. Animals were observed for mortality. 50% mortality was noted at 670 mg/kg bw. Hence, the acute oral LD50 value was considered to be 670 mg/kg body weight, when rats were treated with the given test chemical orally.
Thus, based on the above summarised studies on test chemical, it can be concluded that the LD50 value is between 300-2000 mg/kg bw, for acute oral toxicity. Thus, comparing this value and range with the criteria of CLP regulation, the given test chemical can be classified in ‘Category 4’ for acute oral toxicity.
Acute Inhalation Toxicity:
Acute inhalation toxicity test was conducted in male rats of Sprague-Dawley strain. 5 groups of 10 rats were taken for test. Rats were exposed for 4 hrs and observed for 14 days. Body weight was measured before and after 14 days of observation. Gross pathology was conducted for the animal which died during test and after completion of observation period. At dose 0.24, 0.36 and 0.38 body weight was observed as 70, 39 and 58 grams all are within the normal limits. Moderate to severe diffuse red discoloration of the lungs were seen. Mortality was observed at dose 0.36 and 0.38 at four to five days of exposure and at dose 0.71 and 6.32 death was observed at one to three days. Therefore, the LC50 was considered to be 0.44 mg/l of air (vapour) .When rats were inhaled with the given test chemical.
Another acute inhalation toxicity study was performed in rats at 44 mg/l concentration for 2 hrs of exposure. 2 rats were taken for the test. After exposure period 1 rats were died and other having acute pulmonary edema. Therefore, the LC50 value was considered to be 44 mg/litre concentration, when rats treated with test chemical.
From the above key study, the LC50 value is ≤0.5 mg/L, for acute inhalation toxicity. Thus, comparing this value with the criteria of CLP regulation, the given test chemical can be classified in “Category 1” for acute inhalation toxicity.
Acute Dermal toxicity:
Acute dermal toxicity study was done in guinea pigs using test material.50% mortality observed at dose range 1510-15000 mg/kg, hence, LD50 was considered to be1510-15000 mg/kg body weight. When guinea pigs were treated with test chemical by dermal application.
Justification for classification or non-classification
Based on the above studies on test chemical, it can be concluded that LD50 value is between 300-2000 mg/kg bw, for acute oral toxicity; LD50 value is at dose range 1510-15000 mg/kg, for acute dermal toxicity and LC50 value is ≤0.5 mg/L, for acute inhalation toxicity. Thus, comparing these values and ranges with the criteria of CLP regulation, the given test chemical can be classified in ‘Category 4’ for acute oral toxicity, “Category 1” for acute inhalation toxicity and cannot be classified for acute dermal toxicity.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.